INHALATION POWDER FORMULATIONS CONTAINING ENANTIOMERICALLY PURE BETA-AGONISTS

摘要

The invention relates to inhalation powder formulations containing enantiomerically pure beta-agonists of formula (1), wherein the radicals R1, R2, R3 and R4 are defined as in claims and descriptions and are optionally embodied in the form the pharmaceutically acceptable acid addition salts thereof and are optionally combined with a pharmaceutically acceptable accessory agent. A method for producing said formulations and the use thereof in the form of a drug, in particular as a drug for treating respiratory tract diseases are also disclosed.